⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AXSM News
Axsome Therapeutics, Inc
Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325 for the Treatment of Epilepsy
globenewswire.com
AXSM
Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics
globenewswire.com
AXSM
Axsome Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
AXSM
Halper Sadeh LLC Encourages Axsome Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights
businesswire.com
AXSM
Axsome Therapeutics Recognizes Mental Illness Awareness Week Along with the National Advocacy Community
globenewswire.com
AXSM
Axsome Therapeutics to Report Third Quarter 2025 Financial Results on November 3
globenewswire.com
AXSM